| 000 | 01734 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514161551.0 | ||
| 264 | 0 | _c20040712 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0263-6352 | ||
| 024 | 7 |
_a10.1097/00004872-200311000-00025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStowasser, Michael | |
| 245 | 0 | 0 |
_aHigh rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. _h[electronic resource] |
| 260 |
_bJournal of hypertension _cNov 2003 |
||
| 300 |
_a2149-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenoma _xcomplications |
| 650 | 0 | 4 |
_aAdrenal Gland Neoplasms _xcomplications |
| 650 | 0 | 4 |
_aAdrenal Glands _xblood supply |
| 650 | 0 | 4 | _aAdrenalectomy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAldosterone _xbiosynthesis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFludrocortisone |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperaldosteronism _xcomplications |
| 650 | 0 | 4 | _aHyperplasia |
| 650 | 0 | 4 |
_aHypertension _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMass Screening |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aRenin _xblood |
| 650 | 0 | 4 |
_aSpironolactone _xtherapeutic use |
| 650 | 0 | 4 | _aVeins |
| 700 | 1 | _aGordon, Richard D | |
| 700 | 1 | _aGunasekera, Thanuja G | |
| 700 | 1 | _aCowley, Diane C | |
| 700 | 1 | _aWard, Gregory | |
| 700 | 1 | _aArchibald, Colin | |
| 700 | 1 | _aSmithers, B Mark | |
| 773 | 0 |
_tJournal of hypertension _gvol. 21 _gno. 11 _gp. 2149-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004872-200311000-00025 _zAvailable from publisher's website |
| 999 |
_c14335817 _d14335817 |
||